Disruption of arginase II alters prostate tumor formation in TRAMP mice.

作者: Shannon M. Mumenthaler , Nora Rozengurt , Justin C. Livesay , Anahita Sabaghian , Stephen D. Cederbaum

DOI: 10.1002/PROS.20816

关键词:

摘要: BACKGROUND Arginase II (AII) is involved in the polyamine synthetic pathway, and elevated levels of expression have been found a high proportion prostate cancer samples patients. However, biological function arginase still remains to be elucidated. In this study, we utilized TRAMP mouse model better understand contribution AII on tumor development. METHODS AII was determined prostates from mice at 23 weeks age by real-time RT-PCR Western blot analysis. Additionally, disrupted crossbreeding knockout (AII KO) with order generate TRAMP/AII KO line. each group, genito-urinary (GU) tract weights were pathological evaluation tumors completed. RESULTS AII only detectable those without presence macroscopic tumors; it also absent TRAMP-C2 cell line, which characteristic an advanced tumor. Assessment GU revealed larger average compared mice. greater percentage more pathology group cohort. CONCLUSIONS Based these results, deficiency seems accelerate progression, leading overall stage These findings support possibility that prostatic could potentially useful marker disease progression. Prostate 68: 1561–1569, 2008. © 2008 Wiley-Liss, Inc.

参考文章(38)
S Elgün, A Keskineğe, ERKAN Yilmaz, SÜMER Baltaci, Y Bedük, None, Evaluation of serum arginase activity in benign prostatic hypertrophy and prostatic cancer. International Urology and Nephrology. ,vol. 31, pp. 95- 99 ,(1999) , 10.1023/A:1007132109061
C Peraino, L G Bunville, T N Tahmisian, Chemical, Physical, and Morphological Properties of Ornithine Aminotransferase from Rat Liver Journal of Biological Chemistry. ,vol. 244, pp. 2241- 2249 ,(1969) , 10.1016/S0021-9258(19)78217-9
G A Mitchell, J E Looney, L C Brody, G Steel, M Suchanek, J F Engelhardt, H F Willard, D Valle, Human ornithine-delta-aminotransferase. cDNA cloning and analysis of the structural gene. Journal of Biological Chemistry. ,vol. 263, pp. 14288- 14295 ,(1988) , 10.1016/S0021-9258(18)68219-5
Milton J. Finegold, Francesco J. DeMayo, Roxani Angelopoulou, Norman M. Greenberg, Jeffrey M. Rosen, Brendan F. Boyce, Roberto J. Barrios, Ronald A. Morton, Jeffrey R. Gingrich, Metastatic Prostate Cancer in a Transgenic Mouse Cancer Research. ,vol. 56, pp. 4096- 4102 ,(1996)
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, M. J. Thun, Cancer statistics, 2007. CA: A Cancer Journal for Clinicians. ,vol. 57, pp. 43- 66 ,(2007) , 10.3322/CANJCLIN.57.1.43
Stephen D Cederbaum, Hong Yu, Wayne W Grody, Rita M Kern, Paul Yoo, Ramaswamy K Iyer, Arginases I and II: do their functions overlap? Molecular Genetics and Metabolism. ,vol. 81, pp. 38- 44 ,(2004) , 10.1016/J.YMGME.2003.10.012
Tao Wang, Ann M. Lawler, Gary Steel, Ilkka Sipila, Ann H. Milam, David Valle, Mice lacking ornithine–δ–amino–transferase have paradoxical neonatal hypoornithinaemia and retinal degeneration Nature Genetics. ,vol. 11, pp. 185- 190 ,(1995) , 10.1038/NG1095-185
M. Manteuffel-Cymborowska, W. Chmurzyńska, M. Peska, B. Grzelakowska-Sztabert, Arginine and ornithine metabolizing enzymes in testosterone-induced hypertrophic mouse kidney The International Journal of Biochemistry & Cell Biology. ,vol. 27, pp. 287- 295 ,(1995) , 10.1016/1357-2725(94)00070-R
N. M. Greenberg, F. DeMayo, M. J. Finegold, D. Medina, W. D. Tilley, J. O. Aspinall, G. R. Cunha, A. A. Donjacour, R. J. Matusik, J. M. Rosen, Prostate cancer in a transgenic mouse. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 3439- 3443 ,(1995) , 10.1073/PNAS.92.8.3439
Takaaki Hayashi, Senya Matsufuji, Shin-ichi Hayashi, Characterization of the human antizyme gene Gene. ,vol. 203, pp. 131- 139 ,(1997) , 10.1016/S0378-1119(97)00504-0